Results 81 to 90 of about 4,510,822 (391)

Lessons Learned From a Delayed‐Start Trial of Modafinil for Freezing of Gait in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Freezing of gait (FOG) in people with Parkinson's disease (PwPD) is debilitating and has limited treatments. Modafinil modulates beta/gamma band activity in the pedunculopontine nucleus (PPN), like PPN deep brain stimulation. We therefore tested the hypothesis that Modafinil would improve FOG in PwPD.
Tuhin Virmani, Lakshmi Pillai, Reid D. Landes, Aliyah Glover, Shannon Doerhoff, Jennifer Kleiner, Mitesh Lotia, Rohit Dhall, Edgar Garcia‐Rill   +8 more
wiley   +1 more source

Drug prescription patterns and compliance with WHO and beers criteria in older patients

BMC Geriatrics
Background As the population ages, the prevalence of chronic diseases increases, leading to greater reliance on multiple medications that are conducted to increase the risk of adverse drug reactions (ADR) that may cause higher morbidity and mortality ...
Mahan Malekzadeh, Yousef Khadivi, Seyed Mojtaba Sohrevardi, Golnaz Afzal   +3 more
doaj   +1 more source

Assessment of prescription sales in Ukraine

Zaporožskij Medicinskij Žurnal, 2013
Currently, the state of the national health system (health) is characterized by a low level of funding for medical and pharmaceutical care and the lack of effective methods of free and preferential dispensing of medicines (drugs) and compensation of ...
N. V. Teterich, L. V. Tereshchenko
doaj   +1 more source

Estimated cost of universal public coverage of prescription drugs in Canada

Canadian Medical Association Journal, 2015
Background: With the exception of Canada, all countries with universal health insurance systems provide universal coverage of prescription drugs. Progress toward universal public drug coverage in Canada has been slow, in part because of concerns about ...
S. Morgan, M. Law, J. Daw, Liza Abraham, Danielle Martin   +4 more
semanticscholar   +1 more source

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett, Abigail Dubois, Melanie Leguizamon, Alexander Song, Paula Trujillo, Colin D. McKnight, Ciaran M. Considine, Manus J. Donahue, Daniel O. Claassen   +8 more
wiley   +1 more source

Nonprescribed Antimicrobial Drugs in Latino Community, South Carolina

Emerging Infectious Diseases, 2005
We investigated in a sample of Latinos the practices of antimicrobial drug importation and use of nonprescribed antimicrobial drugs. In interviews conducted with 219 adults, we assessed health beliefs and past and present behaviors consistent with ...
Arch G. Mainous, Andrew Y. Cheng, Rebecca C. Garr, Barbara C. Tilley, Charles J. Everett, M. Diane McKee   +5 more
doaj   +1 more source

Primary Care and Prescription Drugs: Coverage, Cost-Sharing, and Financial Protection in Six European Countries [PDF]

, 2010
Examines health coverage, innovations in cost-sharing design, and affordability of primary care and prescription drugs in Denmark, France, Germany, the Netherlands, Sweden, and the United Kingdom. Explores lessons for U.S.
Elias Mossialos, Sarah Thomson
core  

Bayesian regression discontinuity designs: Incorporating clinical knowledge in the causal analysis of primary care data [PDF]

, 2014
The regression discontinuity (RD) design is a quasi-experimental design that estimates the causal effects of a treatment by exploiting naturally occurring treatment rules.
Baio, Gianluca, Geneletti, Sara, O'Keeffe, Aidan G., Richardson, Sylvia, Sharples, Linda D.   +4 more
core   +5 more sources

​Did a Non‐Medical Biosimilar Switching Policy Cause an Increase in Non‐Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis?

Arthritis Care &Research, EarlyView.
Objective This study aimed to evaluate the impact of a series of policies that mandated switching patients with inflammatory arthritis (IA) from an originator biologic to a biosimilar in British Columbia, Canada, on health care resource use and cost.
HaoHung Dang, Sandra Blitz, Nick Bansback, Michael Law, Mark Harrison   +4 more
wiley   +1 more source

Study on the content of nurse's prescription of drug for endocrine system and metabolic in China by Delphi method

Huli yanjiu, 2019
ObjectiveTo study the content and form of nurse's prescription of drugs for endocrine system and metabolic in China by using Delphi.MethodsThe two rounds of consultations among 42 experts were carried out by Delphi method,And the final research results ...
HOU Yongchao, HAN Shifan
doaj